Correlation Between MedMira and Oxford Cannabinoid

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MedMira and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedMira and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedMira and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on MedMira and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedMira with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedMira and Oxford Cannabinoid.

Diversification Opportunities for MedMira and Oxford Cannabinoid

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between MedMira and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding MedMira and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and MedMira is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedMira are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of MedMira i.e., MedMira and Oxford Cannabinoid go up and down completely randomly.

Pair Corralation between MedMira and Oxford Cannabinoid

Assuming the 90 days horizon MedMira is expected to generate 9.75 times more return on investment than Oxford Cannabinoid. However, MedMira is 9.75 times more volatile than Oxford Cannabinoid Technologies. It trades about 0.13 of its potential returns per unit of risk. Oxford Cannabinoid Technologies is currently generating about -0.07 per unit of risk. If you would invest  6.00  in MedMira on November 3, 2024 and sell it today you would earn a total of  2.47  from holding MedMira or generate 41.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy97.88%
ValuesDaily Returns

MedMira  vs.  Oxford Cannabinoid Technologie

 Performance 
       Timeline  
MedMira 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in MedMira are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, MedMira reported solid returns over the last few months and may actually be approaching a breakup point.
Oxford Cannabinoid 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oxford Cannabinoid Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical indicators, Oxford Cannabinoid is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

MedMira and Oxford Cannabinoid Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MedMira and Oxford Cannabinoid

The main advantage of trading using opposite MedMira and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedMira position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.
The idea behind MedMira and Oxford Cannabinoid Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Insider Screener
Find insiders across different sectors to evaluate their impact on performance